G. Strassmann

发表

STUDIES ON ANTIGENS ASSOCIATED WITH THE ACTIVATION OF MURINE MONONUCLEAR PHAGOCYTES : KINETICS OF AND REQUIREMENTS FOR VITRO ' INDUCTION OF LYMPHOCYTE FUNCTION-ASSOCIATED ( LFA )-1 ANTIGEN IN

G. Strassmann, Timothy, '. A.SPRINGER, 2001 .

A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis.

K. Handa, S. Hakomori, N. Radin, 1990, Biochemistry.

Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.

W. Gauderman, G. Strassmann, C. Jacob, 1998, Arthritis and rheumatism.

Tumor cell IL‐6 gene expression is regulated by IL‐1α/β and TNFα: proposed feedback mechanisms induced by the interaction of tumor cells and macrophages

J. Meyerhardt, G. Strassmann, M. Fong, 1992, Journal of leukocyte biology.

The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia.

S. Lowry, G. Strassmann, T. Kambayashi, 1996, Cancer letters.

The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo.

G. Strassmann, R. Neta, M. Fong, 1993, Cytokine.

Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor.

G. Strassmann, Y. Masui, R. Chizzonite, 1993, Journal of immunology.

Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

G. Strassmann, C. Jacob, J. Kenney, 1992, The Journal of clinical investigation.

THE ROLE OF INTERLEUKIN-6 IN LIPOPOLYSACCHARIDE-INDUCED WEIGHT LOSS , HYPOGLYCEMIA AND FIBRINOGEN PRODUCTION , INVIVO

G. Strassmann, R. Neta, M. Fong, 2022 .

Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia.

G. Strassmann, C. Jacob, M. Fong, 1992, Journal of immunology.

Vesnarinone is a selective inhibitor of macrophage TNFα release

G. Strassmann, C. Jacob, N. Mazurek, 1996 .

Up-regulation by ammonium trichloro(dioxoethylene-0,0') tellurate (AS101) of Fas/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101.

G. Strassmann, B. Sredni, M. Albeck, 1998, Journal of immunology.

Suramin inhibits the stimulation of acute phase plasma protein genes by IL-6-type cytokines in rat hepatoma cells.

G. Strassmann, H. Baumann, 1993, Journal of immunology.

Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: Possible cellular mechanisms of cancer cachexia

D. Fraker, G. Strassmann, H. Alexander, 2006, Annals of Surgical Oncology.

HLA‐DR Expression on Cytotoxic T Lymphocytes

F. Bach, G. Strassmann, S. Ress, 1985, Scandinavian journal of immunology.

Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). I. Blocking of bulk non-DR and non-DQ-directed cytotoxic T cells by MoAb against DR, DQ, and DP.

F. Bach, G. Strassmann, A. Anichini, 1985, Human immunology.

Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury.

G. Strassmann, C. Jacob, H. Baumann, 1997, International journal of immunopharmacology.

Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection.

G. Strassmann, T. Wynn, N. Van Rooijen, 1995, Journal of immunology.

Differential activity of granulocyte-macrophage and macrophage colony stimulating factors on bone resorption in fetal rat long bone organ cultures.

G. Strassmann, D. Bertolini, 1991, Cytokine.

The Immunomodulator AS-101 Inhibits IL-10 Release and Augments TNFα and IL-1α Release by Mouse and Human Mononuclear Phagocytes

D. Sredni, G. Strassmann, C. Jacob, 1997 .

Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.

R. Nordan, G. Strassmann, C. Freter, 1993, The Journal of clinical investigation.

Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine-receptor therapy.

G. Strassmann, T. Kambayashi, Gideon Strassmann, 1995, Cytokines and molecular therapy.

Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.

G. Strassmann, C. Chan, R. Caspi, 1999, Investigative ophthalmology & visual science.

Elicitation of delayed-type hypersensitivity responses to poly(L- Tyr,LGlu)-poly(DLAla)--poly(LLys) by anti-idiotypic antibodies

G. Strassmann, E. Mozes, R. Lifshitz, 1980, The Journal of experimental medicine.

Analysis of human class II antigens by cloned cytolytic T cell reagents: a study using HLA loss mutant lymphoblastoid cell lines and monoclonal antibodies detecting the HLA-DP product(s).

P. Wernet, F. Bach, G. Strassmann, 1985, Human immunology.

Neutrophils augment the release of TNFalpha from LPS-stimulated macrophages via hydrogen peroxide.

G. Strassmann, T. Kambayashi, D. Sredni-Kenigsbuch, 2000, Immunology letters.

Antitumor Effects of AS 101 Melanoma Cells : Implications for the ( AS 101 ) of Fas / Apo-1 Expression on B 16 ) Tellurate ′ Trichloro ( Dioxoethylene-0 , 0 Up-Regulation by Ammonium

G. Strassmann, B. Sredni, M. Albeck, 1998 .

Regulation of murine mononuclear phagocyte inflammatory products by macrophage colony-stimulating factor. Lack of IL-1 and prostaglandin E2 production and generation of a specific IL-1 inhibitor.

G. Strassmann, D. Bertolini, M. Fong, 1991, Journal of immunology.

Mechanisms of paraneoplastic syndromes of colon-26: involvement of interleukin 6 in hypercalcemia.

G. Strassmann, C. Jacob, D. Bertolini, 1993, Cytokine.

Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.

F. Bach, G. Strassmann, J. Zarling, 1983, Journal of immunology.

Endogenous D‐factor activity partially mediates the toxic but not the therapeutic effects of tumor necrosis factor

D. Fraker, G. Strassmann, H. Alexander, 1995, International journal of cancer.

Sudden Death Following Injection of Foreign Protein.

G. Strassmann, B. M. Vance, 1942 .

Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). II. Blocking of anti-class I CTL clones by anti-DR MoAb.

F. Bach, G. Strassmann, A. Anichini, 1985, Human immunology.

Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities.

R. Nordan, G. Strassmann, R. Chizzonite, 1994, International journal of immunopharmacology.

The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice.

G. Strassmann, M. Huberman, B. Sredni, 1998, Cellular immunology.

Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.

G. Strassmann, C. Jacob, N. Mazurek, 1995, Journal of immunology.

Interleukin 6 production in fetal rat long bone cultures is correlated with PGE2 release and does not correlate with the extent of bone resorption.

G. Strassmann, D. Bertolini, B. Votta, 1994, Cytokine.

Biochemical models of interferon-gamma-mediated macrophage activation: independent regulation of lymphocyte function associated antigen (LFA)-1 and I-A antigen on murine peritoneal macrophages.

T. Springer, G. Strassmann, T. Hamilton, 1986, Cellular immunology.

IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes.

G. Strassmann, C. Jacob, T. Kambayashi, 1996, Cellular immunology.

Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.

G. Strassmann, C. Chan, R. Caspi, 1995, Current Eye Research.

Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGlu)-poly(DLAla)--poly(LLys). II. Evidence for a T-T-cell collaboration in delayed-type hypersensitivity responses and for a T- cell defect at the efferent phase in nonresponder H-2k mice

Z. Eshhar, G. Strassmann, E. Mozes, 1980, The Journal of experimental medicine.

Studies on antigens associated with the activation of murine mononuclear phagocytes: kinetics of and requirements for induction of lymphocyte function-associated (LFA)-1 antigen in vitro.

T. Springer, G. Strassmann, D. Adams, 1985, Journal of immunology.

Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2

F. Finkelman, G. Strassmann, T. Kambayashi, 1994, The Journal of experimental medicine.

Mechanisms of tumor cell capture by activated macrophages: evidence for involvement of lymphocyte function-associated (LFA)-1 antigen.

T. Springer, G. Strassmann, D. Adams, 1986, Journal of immunology.

Antigens associated with the activation of murine mononuclear phagocytes in vivo: differential expression of lymphocyte function-associated antigen in the several stages of development.

T. Springer, L. Lanier, G. Strassmann, 1985, Cellular immunology.

Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.

G. Strassmann, B. Kaufman, R. Catane, 1996, Journal of the National Cancer Institute.

Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.

G. Strassmann, B. Sredni, M. Albeck, 1995, Blood.

In vitro and in vivo induction of effector T cells mediating DTH responses to a protein and a synthetic polypeptide antigen.

Z. Eshhar, G. Strassmann, E. Mozes, 1979, Cellular immunology.

Helper cell-independent cytotoxic clones in man

F. Bach, G. Strassmann, S. Wee, 1982, The Journal of experimental medicine.

The phenotype of antigen-specific suppressor T cells generated in human mixed leucocyte culture depends on the nature of the major histocompatibility regions recognized.

F. Bach, G. Strassmann, S. Ress, 1984, Human Immunology.

Lupus-like Autoimmune Disease. Region in the Genetic Predisposition to a Regulatory Role for the 3'-untranslated Mutational Analysis of Tnf-alpha Gene Reveals

G. Strassmann, 2001 .

Inhibition of immune reactions in vivo by liposome associated transforming growth factor (TGF) type β1

O. Eidelman, G. Strassmann, D. Bertouni, 1991, Clinical and experimental immunology.

Effect of platelet-derived transforming growth factor (TGF) type beta 1 on murine inflammatory mononuclear phagocytes: increased fibronectin production.

G. Strassmann, J. Herrfeldt, P. Arthur, 1989, Cellular immunology.

Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3'-untranslated region in the genetic predisposition to lupus-like autoimmune disease.

G. Strassmann, C. Jacob, S. K. Lee, 1996, Journal of immunology.

Regulation of colony-stimulating factor 1-dependent macrophage precursor proliferation by type beta transforming growth factor.

M. Cole, G. Strassmann, W. Newman, 1988, Journal of immunology.

Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10.

G. Strassmann, H. Alexander, T. Kambayashi, 1995, Journal of immunology.

Vesnarinone is a selective inhibitor of macrophage TNF(alpha) release.

G. Strassmann, C. Jacob, N. Mazurek, 1996, International Journal of Immunopharmacology.

Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGu)-poly(DLAla)--poly(LLys). I. Expression of the genetic defect at two phases of the immune process

Z. Eshhar, G. Strassmann, E. Mozes, 1980, The Journal of experimental medicine.

Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

G. Strassmann, C. Jacob, J. Kenney, 1992, The Journal of clinical investigation.

Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2

F. Finkelman, G. Strassmann, T. Kambayashi, 1994, The Journal of experimental medicine.

Inhibition of lipopolysaccharide and IL-1 but not of TNF-induced activation of human endothelial cells by suramin.

G. Strassmann, S. Goyert, M. Fong, 1994, Journal of immunology.